Impas 1 possesses endoproteolytic activity against multipass membrane protein substrate cleaving the presenilin 1 holoprotein

[1]  M. Wolfe,et al.  Presenilin endoproteolysis mediated by an aspartyl protease activity pharmacologically distinct from γ‐secretase , 2003, Journal of neurochemistry.

[2]  S. Yamazaki,et al.  The γ-Secretase Inhibitor N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl Ester Reduces Aβ Levels in Vivo in Plasma and Cerebrospinal Fluid in Young (Plaque-Free) and Aged (Plaque-Bearing) Tg2576 Mice , 2003, Journal of Pharmacology and Experimental Therapeutics.

[3]  B. Martoglio,et al.  Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. , 2002, Molecular cell.

[4]  P. S. St George-Hyslop,et al.  Presenilin 1 Mutations Activate γ42-Secretase but Reciprocally Inhibit ε-Secretase Cleavage of Amyloid Precursor Protein (APP) and S3-Cleavage of Notch* , 2002, The Journal of Biological Chemistry.

[5]  E. Rogaev,et al.  Novel Class of Polytopic Proteins with Domains Associated with Putative Protease Activity , 2002, Biochemistry (Moscow).

[6]  B. Martoglio,et al.  Identification of Signal Peptide Peptidase, a Presenilin-Type Aspartic Protease , 2002, Science.

[7]  B. Ghetti,et al.  Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Yankner,et al.  A RIP Tide in Neuronal Signal Transduction , 2002, Neuron.

[9]  C. Ponting,et al.  Identification of a novel family of presenilin homologues. , 2002, Human molecular genetics.

[10]  Sangram S. Sisodia,et al.  γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in? , 2002, Nature Reviews Neuroscience.

[11]  Graeme Irvine Stevenson,et al.  L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity , 2000 .

[12]  A. Bernstein,et al.  Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1 , 2000, Nature Cell Biology.

[13]  Joseph L Goldstein,et al.  Regulated Intramembrane Proteolysis A Control Mechanism Conserved from Bacteria to Humans , 2000, Cell.

[14]  T. Iwatsubo,et al.  C Terminus of Presenilin Is Required for Overproduction of Amyloidogenic Aβ42 through Stabilization and Endoproteolysis of Presenilin , 1999, The Journal of Neuroscience.

[15]  Toshiki Nakai,et al.  Membrane Topology of Alzheimer’s Disease-related Presenilin 1 , 1999, The Journal of Biological Chemistry.

[16]  D. Selkoe,et al.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.

[17]  William J. Ray,et al.  A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.

[18]  I. Greenwald,et al.  Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Raphael Kopan,et al.  Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.

[20]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[21]  R. Sherrington,et al.  Presenilin Proteins Undergo Heterogeneous Endoproteolysis between Thr291and Ala299and Occur as Stable N- and C-Terminal Fragments in Normal and Alzheimer Brain Tissue , 1997, Neurobiology of Disease.

[22]  D. Borchelt,et al.  Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo , 1996, Neuron.

[23]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[24]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[25]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[26]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.